Reactive Oxygen Species (ROS) in Cancer and Cancer Stem Cells
Abstract
Reactive Oxygen Species (ROS) are aerobic metabolic byproducts, mainly produced by mitochondria. Most types of cancer contain high amounts of ROS. An increase in endogenous ROS triggers adaptive changes, induces oxidative stress and cytotoxic. Oxidative stress can lead to cancer. But on the other hand, the radiotherapy treatment method induces the formation of ROS in the process of cell death. Resistance therapy in cancer cells is associated with high antioxidant enzymes that neutralize ROS in cancer cells. In addition, therapeutic resistance and recurrence are also associated with the presence of cancer stem cells (CSCs). Several studies have shown that ROS levels are found to be low in CSCs. Low levels of ROS are likely to play a role in the survival of CSCs. Therefore, modulation of ROS levels in CSCs can be used as an alternative therapy.DOI : http://dx.doi.org/10.17576/JSKM-2021-1902-05Downloads
Published
Issue
Section
License
It is a condition of publication in the Journal that authors assign copyright to the Penerbit, Universiti Kebangsaan Malaysia, using the form available on the Copyright Assignment Form page. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning copyright, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Penerbit Universiti Kebangsaan Malaysia is notified in writing and in advance.
Our journal offers an open access articles, which is under the Creative Common license type : Attribution-NonCommercial-ShareAlike (CC BY-NC-SA)
